Liquidia (LQDA) EBT Margin (2020 - 2026)
Liquidia's (LQDA) quarterly EBT Margin came in at 42.74% in Q1 2026, up 127245.0% year-on-year from N/an in Q1 2025, and up 170.19% quarter-over-quarter from 15.82% in Q4 2025.
Liquidia (LQDA) EBT Margin (2020 - 2026) Analysis & Trends
Liquidia's EBT Margin history runs 7 years deep, the most recent figure standing at 42.74% for Q1 2026.
- On a quarterly basis, EBT Margin rose 127245.0% year-over-year to 42.74% in Q1 2026; TTM through Mar 2026 was 63.52%, a 167155.0% increase from a year earlier, with the FY2025 full-year figure at 185.5%, up 144819.0% from the prior year.
- EBT Margin improved to 42.74% in Q1 2026 per LQDA's latest filing, from 15.82% in the prior quarter.
- Across five years, EBT Margin topped out at 42.74% in Q1 2026 and bottomed at 4103.67% in Q1 2024.
- The 5-year median for EBT Margin is 690.03% (2023), against an average of 998.13%.
- Across the five-year window, EBT Margin plunged 341364 bps in 2024 and soared 287396 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 121.88% in 2022, then slumped by 290 bps to 475.33% in 2023, then plunged by 178 bps to 1320.19% in 2024, then jumped by 101 bps to 15.82% in 2025, then soared by 170 bps to 42.74% in 2026.
- Per Business Quant, the three latest LQDA EBT Margin figures stand at 42.74% (Q1 2026), 15.82% (Q4 2025), and 275.86% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 42.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.74% |
| Dec 31, 2025 | 15.82% |
| Sep 30, 2025 | -275.86% |
| Jun 30, 2025 | -1,181.31% |
| Mar 31, 2025 | -1,229.71% |
| Dec 31, 2024 | -1,320.19% |
| Sep 30, 2024 | -1,690.85% |
| Jun 30, 2024 | -2,550.48% |
| Mar 31, 2024 | -4,103.67% |
| Dec 31, 2023 | -475.33% |
| Sep 30, 2023 | -847.82% |
| Jun 30, 2023 | -1,108.02% |
| Mar 31, 2023 | -690.03% |
| Dec 31, 2022 | -121.88% |
| Sep 30, 2022 | -612.16% |
| Jun 30, 2022 | -366.31% |
| Mar 31, 2022 | -453.15% |
| Dec 31, 2021 | -359.66% |
| Sep 30, 2021 | -432.21% |
| Jun 30, 2021 | -235.87% |